Back to Search Start Over

Tizona Announces Publication in Cancer Discovery Highlighting the Important Role of CD39 and Extracellular ATP in Inflammasome-driven Anti-Tumor Immunity

Source :
Cancer Weekly. November 19, 2019, 184
Publication Year :
2019

Abstract

2019 NOV 19 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Tizona Therapeutics, Inc., a clinical stage, privately held company developing first-in-class cancer immunotherapies, announced the [...]

Details

Language :
English
ISSN :
15324567
Database :
Gale General OneFile
Journal :
Cancer Weekly
Publication Type :
News
Accession number :
edsgcl.605997581